about
Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol TreatmentAntibiotic toxicity and absorption in zebrafish using liquid chromatography-tandem mass spectrometryAntibiotic Treatment of Dogs and Cats during Pregnancy.Pregnancy and Protection: The Ethics of Limiting a Pregnant Woman's Participation in Clinical TrialsAbortion decisions as inclusion and exclusion criteria in research involving pregnant women and fetuses.How should risks and benefits be balanced in research involving pregnant women and fetuses?Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women.A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.Psychopharmacology decision-making among pregnant and postpartum women and health providers: informing compassionate and collaborative care women's health.Sex-specific differences in CYP450 isoforms in humans.The second wave: Toward responsible inclusion of pregnant women in researchPhysiologic and pharmacokinetic changes in pregnancy.Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.Pharmacokinetic studies in pregnant women.Integrating Behavioral Health Risk Assessment into Centralized Intake for Maternal and Child Health Services.Towards an appropriate framework to facilitate responsible inclusion of pregnant women in drug development programs.The National Children's Study: a golden opportunity to advance the health of pregnant women.Ethical Challenges in Designing, Conducting, and Reporting Research to Improve the Mental Health of Pregnant Women: The Voices of Investigators and IRB MembersEthical Barriers to Perinatal Mental Health Research and Evidence-Based Treatment: An Empirical StudyDrug development for use during pregnancy: impact of the placenta
P2860
Q24239840-80B5F9D6-82CD-4480-95C1-FAB31B689027Q28546965-47B3CB12-5264-43A3-A3E8-2559138C414FQ34495464-A3AEC6C7-0C1D-4CDB-B626-8EAE1FDACD61Q35173172-10A67224-E156-4C8F-A04C-06A8285E5DB9Q35621608-16F52CAB-09FC-423A-AF17-9A5ADCBD4708Q35650552-E0CFB3DC-4F17-42BF-854E-23DAF29F96BEQ36084313-1E366A6E-7D42-465A-8E11-3B147B2BABD3Q36390289-0AF58360-0D0A-412C-AD2E-B6AD174AC907Q36620257-4B4FCEA5-C2B9-42CE-BE10-6D3FE7EF3CFAQ36822137-4D1E1CCC-1852-4EC5-A0E2-DE623F66F8DCQ37181876-C0878BFF-34EC-4CCA-9730-B55C34A3EC6CQ37354964-7B3644D2-08B7-4DF2-BE34-88F6851ECF1FQ37695386-2EDE4FE0-7F5B-4AF7-A70C-856E2D032291Q38802632-1093043C-18D0-4EC0-9FA7-74B68236880FQ38841163-3C21FB02-84FA-4FAB-87B2-FE5D812BC15AQ42007783-0012CD94-5028-43A0-A88A-C7241EBA5891Q45069895-222A7758-513C-495B-858A-636351A086F6Q49843269-B2806641-9B47-411A-BA83-F10024E55B62Q55658486-8CEC287A-8E1D-477E-B4EA-C368B80C2505Q57795382-42C80097-13B6-45CF-AD45-D0D333047F3CQ58145178-58D94DD3-9590-4C7F-B77F-D84CCA708A57Q58392274-AAEDDC27-EF48-4343-A3B2-CDCC8CF41538
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Gaps in knowledge in treating pregnant women.
@ast
Gaps in knowledge in treating pregnant women.
@en
type
label
Gaps in knowledge in treating pregnant women.
@ast
Gaps in knowledge in treating pregnant women.
@en
prefLabel
Gaps in knowledge in treating pregnant women.
@ast
Gaps in knowledge in treating pregnant women.
@en
P1433
P1476
Gaps in knowledge in treating pregnant women
@en
P2093
Anne Zajicek
P304
P356
10.1016/S1550-8579(06)80205-6
P577
2006-09-01T00:00:00Z